Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.

Journal: Cell
Published:
Abstract

T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and nucleocapsid not captured by current vaccines. Some peptides from out-of-frame ORFs elicited T cell responses in a humanized mouse model and individuals with COVID-19 that exceeded responses to canonical peptides, including some of the strongest epitopes reported to date. Whole-proteome analysis of infected cells revealed that early expressed viral proteins contribute more to HLA-I presentation and immunogenicity. These biological insights, as well as the discovery of out-of-frame ORF epitopes, will facilitate selection of peptides for immune monitoring and vaccine development.

Authors
Shira Weingarten Gabbay, Susan Klaeger, Siranush Sarkizova, Leah Pearlman, Da-yuan Chen, Kathleen M Gallagher, Matthew Bauer, Hannah Taylor, W Dunn, Christina Tarr, John Sidney, Suzanna Rachimi, Hasahn Conway, Katelin Katsis, Yuntong Wang, Del Leistritz Edwards, Melissa Durkin, Christopher Tomkins Tinch, Yaara Finkel, Aharon Nachshon, Matteo Gentili, Keith Rivera, Isabel Carulli, Vipheaviny Chea, Abishek Chandrashekar, Cansu Bozkus, Mary Carrington, Dan Barouch, Alessandro Sette, Marcela Maus, Charles Rice, Karl Clauser, Derin Keskin, Daniel Pregibon, Nir Hacohen, Steven Carr, Jennifer Abelin, Mohsan Saeed, Pardis Sabeti